What Immunotherapy Combination Is Best in Metastatic Bladder Cancer?

Extended follow-up from the CheckMate 032 trial showed strong results with three different immunotherapy regimens involving nivolumab and ipilimumab in patients with previously treated metastatic urothelial carcinoma.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news